These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6889190)

  • 1. The patient, disease status, and treatment options for prostate cancer: stages B1 and B2.
    Herr HW
    Prostate; 1983; 4(5):447-59. PubMed ID: 6889190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
    Kwon ED; Loening SA; Hawtrey CE
    J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present status of radical prostatectomy for stages A and B prostatic cancer.
    Jewett HJ
    Urol Clin North Am; 1975 Feb; 2(1):105-24. PubMed ID: 1128746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
    Cheng CW; Bergstralh EJ; Zincke H
    Cancer; 1993 Feb; 71(3 Suppl):996-1004. PubMed ID: 7679047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
    Zagars GK; von Eschenbach AC; Ayala AG
    Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold seed implantation in prostate brachytherapy.
    Loening SA
    Semin Surg Oncol; 1997; 13(6):419-24. PubMed ID: 9358588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for carcinoma of the prostate.
    Culp DA
    Prog Clin Biol Res; 1976; 6():235-41. PubMed ID: 1023210
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome.
    Feneley MR; Gillatt DA; Hehir M; Kirby RS
    Br J Urol; 1996 Dec; 78(6):911-8; discussion 919-20. PubMed ID: 9014719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectant management of localized prostatic cancer.
    Whitmore WF; Warner JA; Thompson IM
    Cancer; 1991 Feb; 67(4):1091-6. PubMed ID: 1991257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital.
    Lepor H; Walsh PC
    NCI Monogr; 1988; (7):117-22. PubMed ID: 3173497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy with adjuvant radioactive gold for prostatic cancer: a preliminary report.
    Rosenberg SJ; Loening SA; Hawtrey CE; Narayana AS; Culp DA
    J Urol; 1985 Feb; 133(2):225-7. PubMed ID: 3968737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
    Zelefsky MJ; Whitmore WF
    J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for prostatic cancer: patient selection and the impact of local control.
    Kaplan ID; Cox RS; Bagshaw MA
    Urology; 1994 May; 43(5):634-9. PubMed ID: 8165765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy for stage B2 prostatic cancer.
    Middleton RG; Smith JA
    J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined gold seed implantation and external radiotherapy for stage B2 or C prostate cancer.
    Carey PO; Lippert MC; Constable WC; Jones D; Talton BM
    J Urol; 1988 May; 139(5):989-94. PubMed ID: 3129585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.